Richard Scheff Named a Health Care/Life Science Law Trailblazer
Richard Scheff, Partner and Leader – Eastern U.S. at Armstrong Teasdale, has been named to the National Law Journal’s list of Health Care/Life Science Law Trailblazers. The Trailblazer series is a special supplement developed by the journal to highlight agents of change in various practice areas. The Health Care/Life Science section features honorees working on a range of issues, including life science litigation, the opioid epidemic, medical marijuana and more.
A nationally recognized trial lawyer and leader of the firm’s strategic growth on the East Coast, Scheff focuses his practice primarily on government and corporate investigations with a particular focus on the pharmaceutical, medical device and financial services industries. His pharmaceutical and medical device experience includes matters involving the False Claims Act, off-label promotion, Medicaid best price law, nominal pricing, co-pay foundations, patient assistance programs, sponsorships, patient advocacy programs and claims under the Anti-Kickback Act.
A profile of Scheff appears in the journal’s April 2020 issue (subscription required).
